PMID- 27321991 OWN - NLM STAT- MEDLINE DCOM- 20180604 LR - 20220410 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 6 DP - 2016 Jun 20 TI - Alpinetin attenuates inflammatory responses by suppressing TLR4 and NLRP3 signaling pathways in DSS-induced acute colitis. PG - 28370 LID - 10.1038/srep28370 [doi] LID - 28370 AB - Alpinetin, a composition of Alpinia katsumadai Hayata, has been reported to have a number of biological properties, such as antibacterial, antitumor and other important therapeutic activities. However, the effect of alpinetin on inflammatory bowel disease (IBD) has not yet been reported. The purpose of this study was to investigate the anti-inflammatory effect and mechanism of alpinetin on dextran sulfate sodium (DSS)-induced colitis in mice. In vivo, DSS-induced mice colitis model was established by giving mice drinking water containing 5% (w/v) DSS for 7 days. Alpinetin (25, 50 and 100 mg/kg) were administered once a day by intraperitoneal injection 3 days before DSS treatment. In vitro, phorbol myristate acetate (PMA)-differentiated monocytic THP-1 macrophages were treated with alpinetin and stimulated by lipopolysaccharide (LPS). The results showed that alpinetin significantly attenuated diarrhea, colonic shortening, histological injury, myeloperoxidase (MPO) activity and the expressions of tumor necrosis factor (TNF-alpha) and interleukin (IL-1beta) production in mice. In vitro, alpinetin markedly inhibited LPS-induced TNF-alpha and IL-1beta production, as well as Toll-like receptor 4 (TLR4) mediated nuclear transcription factor-kappaB (NF-kappaB) and NOD-like receptor protein 3 (NLRP3) inflammasome activation. In conclusion, this study demonstrated that alpinetin had protective effects on DSS-induced colitis and may be a promising therapeutic reagent for colitis treatment. FAU - He, Xuexiu AU - He X AD - College of Veterinary Medicine, Jilin University, Jilin, Changchun 130062, People's Republic of China. FAU - Wei, Zhengkai AU - Wei Z AD - College of Veterinary Medicine, Jilin University, Jilin, Changchun 130062, People's Republic of China. FAU - Wang, Jingjing AU - Wang J AD - College of Veterinary Medicine, Jilin University, Jilin, Changchun 130062, People's Republic of China. FAU - Kou, Jinhua AU - Kou J AD - College of Veterinary Medicine, Jilin University, Jilin, Changchun 130062, People's Republic of China. FAU - Liu, Weijian AU - Liu W AD - College of Veterinary Medicine, Jilin University, Jilin, Changchun 130062, People's Republic of China. FAU - Fu, Yunhe AU - Fu Y AD - College of Veterinary Medicine, Jilin University, Jilin, Changchun 130062, People's Republic of China. FAU - Yang, Zhengtao AU - Yang Z AD - College of Veterinary Medicine, Jilin University, Jilin, Changchun 130062, People's Republic of China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20160620 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (Flavanones) RN - 0 (Inflammasomes) RN - 0 (Interleukin-1beta) RN - 0 (Lipopolysaccharides) RN - 0 (NF-kappa B) RN - 0 (NLR Family, Pyrin Domain-Containing 3 Protein) RN - 0 (NLRP3 protein, human) RN - 0 (Tlr4 protein, mouse) RN - 0 (Toll-Like Receptor 4) RN - 0 (Tumor Necrosis Factor-alpha) RN - 0 (alpinetin) RN - 9042-14-2 (Dextran Sulfate) RN - EC 1.11.1.7 (Peroxidase) RN - NI40JAQ945 (Tetradecanoylphorbol Acetate) SB - IM MH - Animals MH - Cell Survival MH - Colitis/chemically induced/*immunology MH - Dextran Sulfate MH - Female MH - Flavanones/*pharmacology MH - Humans MH - Inflammasomes/metabolism MH - Inflammation/*drug therapy MH - Injections, Intraperitoneal MH - Interleukin-1beta/metabolism MH - Lipopolysaccharides MH - Macrophages/metabolism MH - Mice MH - Mice, Inbred BALB C MH - NF-kappa B/metabolism MH - NLR Family, Pyrin Domain-Containing 3 Protein/*metabolism MH - Peroxidase/metabolism MH - *Signal Transduction MH - THP-1 Cells/cytology MH - Tetradecanoylphorbol Acetate MH - Toll-Like Receptor 4/*metabolism MH - Tumor Necrosis Factor-alpha/metabolism PMC - PMC4913257 EDAT- 2016/06/21 06:00 MHDA- 2018/06/05 06:00 PMCR- 2016/06/20 CRDT- 2016/06/21 06:00 PHST- 2015/11/15 00:00 [received] PHST- 2016/06/03 00:00 [accepted] PHST- 2016/06/21 06:00 [entrez] PHST- 2016/06/21 06:00 [pubmed] PHST- 2018/06/05 06:00 [medline] PHST- 2016/06/20 00:00 [pmc-release] AID - srep28370 [pii] AID - 10.1038/srep28370 [doi] PST - epublish SO - Sci Rep. 2016 Jun 20;6:28370. doi: 10.1038/srep28370.